Aberrant expression of N-glycolyl GM3 ganglioside is associated with the aggressive biological behavior of human sarcomas-Reference-Cited by-同舟云学术

Aberrant expression of N-glycolyl GM3 ganglioside is associated with the aggressive biological behavior of human sarcomas

Published:2019-06-10 Issue:1 Volume:19 Page:
ISSN:1471-2407
Container-title:BMC Cancer
language:en
Short-container-title:BMC Cancer

Author:

Pilco-Janeta Daniel^ORCID,De la Cruz Puebla Myriam,Soriano Jorge,Osorio Marta,Caballero Iraida,Pérez Adanays Calvo,Savon Laynes,Cremades Natalia,Blanco Rancés,Carr Adriana

Funder

National Secretary of Higher Education, Science, Technology and Innovation

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Oncology

Link

http://link.springer.com/content/pdf/10.1186/s12885-019-5743-9.pdf

Reference31 articles.

1. Judson I, Verweij J, Gelderblom H, Hartmann JT, Schöffski P, Blay J-Y, et al. Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trial. Lancet Oncol. 2014 Apr;15(4):415–23.

2. Frezza AM, Stacchiotti S, Gronchi A. Systemic treatment in advanced soft tissue sarcoma: what is standard, what is new. BMC Med [Internet]. 2017;15(1) Available from: http://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-017-0872-y .

3. Kanduma EG, Mukuria JC, Mwanda OW. Serum total sialic acid and Hanganutziu-Deicher antibody in normals and in cancer patients. East Afr Med J. 2007 May;84(5):207–14.

4. Roth M, Linkowski M, Tarim J, Piperdi S, Sowers R, Geller D, et al. Ganglioside GD2 as a therapeutic target for antibody-mediated therapy in patients with osteosarcoma: GD2 as a target in osteosarcoma. Cancer. 2014;120(4):548–54.

5. Irie A, Suzuki A. CMP-N-Acetylneuraminic acid hydroxylase is exclusively inactive in humans. Biochem Biophys Res Commun. 1998 Jul;248(2):330–3.

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mesenchymal Stem Cells and Sarcoma;Comprehensive Hematology and Stem Cell Research;2024

2. Pathophysiological roles and applications of glycosphingolipids in the diagnosis and treatment of cancer diseases;Progress in Lipid Research;2023-07

3. N-glycolylneuraminic acid as a carbohydrate cancer biomarker;Translational Oncology;2023-05

4. SILAC-based quantitative proteomics and microscopy analysis of cancer cells treated with the N-glycolyl GM3-specific anti-tumor antibody 14F7;Frontiers in Immunology;2022-11-09

5. A Potential Prognostic Marker for Recognizing VEGF-Positive Hepatocellular Carcinoma Based on Magnetic Resonance Radiomics Signature;Frontiers in Oncology;2022-04-04